Price, J (Jason)
Latest papers:
Wendy Maury,
Jason Price,
Melinda Brindley,
Choonseok Oh,
Jeffrey Neighbors,
David Wiemer,
Nickolas Wills,
Susan Carpenter,
Cathy Hauck,
Patricia Murphy,
Mark Widrlechner,
Kathleen Delate,
Ganesh Kumar,
George Kraus,
Ludmila Rizshsky,
Basil Nikolau
ABSTRACT: BACKGROUND: Light-dependent activities against enveloped viruses in St. John's Wort (Hypericum perforatum) extracts have been extensively studied. In contrast, light-independent antiviral activity from this species has not. Results. Here, we identify the light-independent inhibition of human immunodeficiency virus-1 (HIV-1) by highly purified fractions of chloroform extracts of H. perforatum. Both cytotoxicity and antiviral activity were evident in initial chloroform extracts, but bioassay-guided fractionation produced fractions that inhibited HIV-1 with little to no cytotoxicity. Separation of these two biological activities has not been reported for constituents responsible for the light-dependent antiviral activities. Antiviral activity was associated with more polar subfractions. GC/MS analysis of the two most active subfractions identified 3-hydroxy lauric acid as predominant in one fraction and 3-hydroxy myristic acid as predominant in the other. Synthetic 3-hydroxy lauric acid inhibited HIV infectivity without cytotoxicity, suggesting that this modified fatty acid is likely responsible for observed antiviral activity. As production of 3-hydroxy fatty acids by plants remains controversial, H. perforatum seedlings were grown sterilely and evaluated for presence of 3-hydroxy fatty acids by GC/MS. Small quantities of some 3-hydroxy fatty acids were detected in sterile plants, whereas different 3-hydroxy fatty acids were detected in our chloroform extracts or field-grown material. Conclusions: Through bioguided fractionation, we have identified that 3-hydroxy lauric acid found in field grown Hypericum perforatum has anti-HIV activity. This novel anti-HIV activity can be potentially developed into inexpensive therapies, expanding the current arsenal of anti-retroviral agents.
Jason Price,
Nicholas White,
Alejandro Perez-Velasco,
Geoffrey Jameson,
Christopher Hunter,
Sally Brooker
Department of Chemistry and MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Otago, P.O. Box 56, Dunedin, New Zealand, Institute of Fundamental Sciences, Chemistry, Massey University, P.O. Box, 11222, Palmerston North, New Zealand, Krebs Institute for Biomedical Science, Department of Chemistry, University of Sheffield, Sheffield, United Kingdom sbrooker@chemistry.otago.ac.nz.
Silver(I) complexes of five bis-bidentate Schiff-base ligands, derived from 3,6-diformylpyridazine and substituted anilines (2,4-dimethylaniline L ( o,p - Me ); 3,5-dichloroaniline L ( m,m - Cl ); 2-aminobiphenyl L ( o - Ph ); p-toluidine L ( p - Me ); 4-aminophenol L ( p - OH ); p-anisidine L ( p - OMe )), have been prepared. The ligands have a wide range of steric and electronic properties due to variation in the extent and nature of the substitution of the aniline rings. Four of the resulting complexes were structurally characterized by X-ray crystallography: three of the four,[Ag 2( L ( o,p - Me )) 2](BF 4) 2,[Ag 2( L ( m,m - Cl )) 2](BF 4) 2 and [Ag 2( L ( o - Ph )) 2](BF 4) 2 formed dinuclear side-by-side complexes, while [Ag 4( L ( p - Me )) 4](BF 4) 4 gave a tetranuclear [2 x 2] grid. The previously reported tetranuclear [2 x 2] grid [Ag 4( L ( p - OMe )) 4](BF 4) 4 was recrystallized in the presence of benzene to see if this would alter the architecture of this complex. It did not: the [2 x 2] grid architecture was retained despite the benzene molecules of solvation. Given the flexibility of silver(I) with regard to coordination geometry, the molecular structure of these complexes is influenced mostly by the ligand rather than the metal ion. In each case, the factors which influence the molecular architecture are presented and discussed. Substituent effects on the electrostatics of the intramolecular ligand-ligand pi-pi interactions (XED2.8) account for some of the differences observed in the structures.
Most cited papers:
Sebastian Biglione,
Sarah Byers,
Jason Price,
Van Trung Nguyen,
Olivier Bensaude,
David Price,
Wendy Maury
ABSTRACT: BACKGROUND: The positive transcription elongation factor, P-TEFb, comprised of Cdk9 and cyclin T1, T2 or K regulates the productive elongation phase of RNA polymerase II (Pol II) dependent transcription of cellular and integrated viral genes. P-TEFb containing cyclin T1 is recruited to the HIV long terminal repeat (LTR) by binding to HIV Tat which in turn binds to the nascent HIV transcript. Within the cell, P-TEFb exists as a kinase-active, free form and a larger, kinase-inactive form that is believed to serve as a reservoir for the smaller form. RESULTS: We developed a method to rapidly quantitate the relative amounts of the two forms based on differential nuclear extraction. Using this technique, we found that titration of the P-TEFb inhibitors flavopiridol, DRB and seliciclib onto HeLa cells that support HIV replication led to a dose dependent loss of the large form of P-TEFb. Importantly, the reduction in the large form correlated with a reduction in HIV-1 replication such that when 50% of the large form was gone, HIV-1 replication was reduced by 50%. Some of the compounds were able to effectively block HIV replication without having a significant impact on cell viability. The most effective P-TEFb inhibitor flavopiridol was evaluated against HIV-1 in the physiologically relevant cell types, peripheral blood lymphocytes (PBLs) and monocyte derived macrophages (MDMs). Flavopiridol was found to have a smaller therapeutic index (LD50/IC50) in long term HIV infectivity studies in primary cells due to greater cytotoxicity and reduced efficacy at blocking HIV replication. CONCLUSIONS: Initial short term studies with P-TEFb inhibitors demonstrated a dose dependent loss of the large form of P-TEFb within the cell and a concomitant reduction in HIV-1 infectivity without significant cytotoxicity. These findings suggested that inhibitors of P-TEFb may serve as effective anti-HIV-1 therapies. However, longer term HIV-1 replication studies indicated that these inhibitors were more cytotoxic and less efficacious against HIV in the primary cell cultures.
Department of Agriculture, Food, and Nutritional Science, 4-10 Ag/For Centre, University of Alberta, Edmonton, AB, Canada, T6G 2P5. grant.clark@ualberta.net
Odor and greenhouse gas (GHG) emissions from stored pig (Sus scrofa) manure were monitored for response to changes in the crude protein level (168 or 139 g kg(-1), as-fed basis) and nonstarch polysaccharide (NSP) content [i.e., control, or modified with beet pulp (Beta vulgaris L.), cornstarch, or xylanase] of diets fed to pigs in a production setting. Each diet was fed to one of eight pens of pigs according to a 2 x 4, full-factorial design, replicated over three time blocks with different groups of animals and random assignment of diets. Manure from each treatment was characterized and stored in a separate, ventilated, 200-L vessel. Repeated measurements of odor, carbon dioxide (CO2), methane (CH4), and nitrous oxide (N2O) emissions from the vessels were taken every two weeks for eight weeks. Manure from high-protein diets had higher sulfur concentration and pH (P < or = 0.05). High-NSP (beet pulp) diets resulted in lower manure nitrogen and ammonia concentrations and pH (P < or = 0.05). Odor level and hedonic tone of exhaust air from the storage vessel headspaces were unaffected by the dietary treatments. Mean CO2 and CH4 emissions (1400 and 42 g d(-1) m(-3) manure, respectively) increased with lower dietary protein (P < or = 0.05). The addition of xylanase to high-protein diets caused a decrease in manure CO2 emissions, but an increase when added to low-protein diets (P < or = 0.05). Nitrous oxide emissions were negligible. Contrary to other studies, these results do not support the use of dietary protein reduction to reduce emissions from stored swine manure.
